Alkermes (ALKS) Asset Utilization Ratio (2011 - 2026)
Alkermes (ALKS) posted quarterly Asset Utilization Ratio of 0.39 for Q2 2026, down 44.49% year-over-year from 0.69 in Q2 2025, and down 16.78% quarter-over-quarter from 0.46 in Q1 2026.
Alkermes (ALKS) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Asset Utilization Ratio for 16 consecutive years, with 0.39 the latest figure, recorded in Q2 2026.
- In Q2 2026, Asset Utilization Ratio fell 44.49% year-over-year to 0.39; the TTM figure through Jun 2026 stood at 0.39 (down 44.49% YoY), while the FY2025 annual figure was 0.65, down 12.56% from the prior year.
- Asset Utilization Ratio declined to 0.39 in Q2 2026 per ALKS's latest filing, from 0.46 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.81 in Q1 2024 and bottomed at 0.3 in Q4 2022.
- Historically, Asset Utilization Ratio has averaged 0.58 across 5 years, with a median of 0.64 in 2025.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio tumbled 48.66% — and 2024, when it surged 163.06%.
- Alkermes' Asset Utilization Ratio stood at 0.3 in 2022, then surged by 149.56% to 0.75 in 2023, then fell by 1.81% to 0.74 in 2024, then retreated by 17.16% to 0.61 in 2025, then sank by 37.09% to 0.39 in 2026.
- Business Quant data shows ALKS's Asset Utilization Ratio at 0.39 in Q2 2026, 0.46 in Q1 2026, and 0.61 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.50 Bn | 397.90 Mn | 0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.39 |
| Mar 31, 2026 | 0.46 |
| Dec 31, 2025 | 0.61 |
| Sep 30, 2025 | 0.66 |
| Jun 30, 2025 | 0.69 |
| Mar 31, 2025 | 0.73 |
| Dec 31, 2024 | 0.74 |
| Sep 30, 2024 | 0.69 |
| Jun 30, 2024 | 0.70 |
| Mar 31, 2024 | 0.81 |
| Dec 31, 2023 | 0.75 |
| Sep 30, 2023 | 0.71 |
| Jun 30, 2023 | 0.59 |
| Mar 31, 2023 | 0.31 |
| Dec 31, 2022 | 0.30 |
| Sep 30, 2022 | 0.31 |
| Jun 30, 2022 | 0.46 |
| Mar 31, 2022 | 0.60 |
| Dec 31, 2021 | 0.58 |
| Sep 30, 2021 | 0.57 |